Name
rhi
Label
EndoPat: Reactive Hyperemia Index
Type
numeric
Visit vs EndoPat: Reactive Hyperemia Index
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline | 313 | 2.0 | ± 0.5 | 1.9 | 1.0 | 4.2 | 5 | 318 |
| Final | 292 | 2.1 | ± 0.6 | 2.0 | 1.0 | 5.8 | 9 | 301 |
Treatment Arm vs EndoPat: Reactive Hyperemia Index
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 313 | 2.0 | ± 0.5 | 1.9 | 1.0 | 4.2 | 5 | 318 |
| HLSE | 105 | 2.1 | ± 0.6 | 1.9 | 1.2 | 4.2 | 1 | 106 |
| HLSE-O | 102 | 1.9 | ± 0.4 | 1.8 | 1.2 | 3.4 | 4 | 106 |
| HLSE-P | 106 | 2.0 | ± 0.5 | 1.9 | 1.0 | 3.4 | - | 106 |
Treatment Arm vs EndoPat: Reactive Hyperemia Index
Final
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 292 | 2.1 | ± 0.6 | 2.0 | 1.0 | 5.8 | 8 | 300 |
| HLSE | 97 | 2.2 | ± 0.7 | 2.1 | 1.2 | 5.8 | 3 | 100 |
| HLSE-O | 97 | 2.0 | ± 0.6 | 1.9 | 1.0 | 3.9 | 4 | 101 |
| HLSE-P | 98 | 2.0 | ± 0.5 | 2.0 | 1.1 | 3.3 | 1 | 99 |
Age vs EndoPat: Reactive Hyperemia Index
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 313 | 2.0 | ± 0.5 | 1.9 | 1.0 | 4.2 | 5 | 318 |
| 45-54 years | 53 | 2.0 | ± 0.5 | 1.9 | 1.0 | 3.1 | - | 53 |
| 55-64 years | 138 | 2.0 | ± 0.5 | 1.8 | 1.1 | 4.2 | 1 | 139 |
| 65-74 years | 117 | 2.0 | ± 0.6 | 1.9 | 1.2 | 3.7 | 4 | 121 |
| 75 or older | 5 | 2.5 | ± 1.1 | 2.2 | 1.4 | 4.0 | - | 5 |
Age vs EndoPat: Reactive Hyperemia Index
Final
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 292 | 2.1 | ± 0.6 | 2.0 | 1.0 | 5.8 | 8 | 300 |
| 45-54 years | 48 | 2.0 | ± 0.5 | 1.9 | 1.2 | 3.3 | 1 | 49 |
| 55-64 years | 124 | 2.0 | ± 0.5 | 1.9 | 1.2 | 3.9 | 3 | 127 |
| 65-74 years | 115 | 2.2 | ± 0.7 | 2.0 | 1.0 | 5.8 | 4 | 119 |
| 75 or older | 5 | 2.2 | ± 0.5 | 2.5 | 1.7 | 2.7 | - | 5 |
Gender vs EndoPat: Reactive Hyperemia Index
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 313 | 2.0 | ± 0.5 | 1.9 | 1.0 | 4.2 | 5 | 318 |
| Male | 230 | 1.9 | ± 0.5 | 1.8 | 1.0 | 4.2 | 4 | 234 |
| Female | 83 | 2.2 | ± 0.6 | 2.1 | 1.1 | 3.7 | 1 | 84 |
Gender vs EndoPat: Reactive Hyperemia Index
Final
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 292 | 2.1 | ± 0.6 | 2.0 | 1.0 | 5.8 | 9 | 301 |
| Male | 215 | 2.0 | ± 0.6 | 1.9 | 1.1 | 5.8 | 7 | 222 |
| Female | 77 | 2.2 | ± 0.7 | 2.2 | 1.0 | 4.1 | 2 | 79 |
Race vs EndoPat: Reactive Hyperemia Index
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 313 | 2.0 | ± 0.5 | 1.9 | 1.0 | 4.2 | 5 | 318 |
| African American or Black | 40 | 2.1 | ± 0.6 | 2.1 | 1.0 | 3.4 | 2 | 42 |
| Caucasian | 249 | 2.0 | ± 0.5 | 1.9 | 1.1 | 4.2 | 3 | 252 |
| Other | 24 | 2.0 | ± 0.6 | 1.8 | 1.3 | 3.7 | - | 24 |
Race vs EndoPat: Reactive Hyperemia Index
Final
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 292 | 2.1 | ± 0.6 | 2.0 | 1.0 | 5.8 | 8 | 300 |
| African American or Black | 37 | 2.1 | ± 0.5 | 2.3 | 1.0 | 3.1 | 3 | 40 |
| Caucasian | 232 | 2.1 | ± 0.6 | 2.0 | 1.1 | 5.8 | 5 | 237 |
| Other | 23 | 2.0 | ± 0.6 | 2.1 | 1.3 | 3.2 | - | 23 |